Ardelyx (ARDX)
Commercializes IBSRELA and XPHOZAH from a gut-local NHE3 inhibition platform.
$3.59
After-hours close−0.04 (−1.21%)
At close$3.63(+3.71%)
Something off on this page? Send us feedback.
Next report
Oct 29, 26
in 37 days
EPS estimate
−$0.03
Revenue estimate
$129.2M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Oct '25Feb '26Apr '26Aug '26Oct '26
Reported$0.02−$0.17−$0.08$0.00$0.02−$0.15−$0.07Pending
Estimate$0.02−$0.10−$0.13−$0.06$0.02−$0.13−$0.07−$0.03
Surprise0.0%−70.0%+38.5%+93.3%0.0%−15.4%−7.0%—
RevenueReportedEstimate
Feb '25May '25Aug '25Oct '25Feb '26Apr '26Aug '26Oct '26
Reported$116.1M$74.1M$97.7M$110.3M$125.2M$94.5M$120.9MPending
Estimate$74.5M$79.4M$94.6M$119.1M$118.0M$92.8M$121.0M$129.2M
Surprise+55.8%−6.7%+3.2%−7.3%+6.1%+1.8%−0.1%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.29 | — | — |
| Sep 2028 | $0.24 | — | — |
| Jun 2028 | $0.21 | — | — |
| Mar 2028 | $0.07 | — | — |
| Dec 2027 | $0.10 | — | — |
| Sep 2027 | $0.06 | — | — |
| Jun 2027 | $0.03 | — | — |
| Mar 2027 | −$0.07 | — | — |
| Dec 2026 | $0.04 | — | — |
| Oct 2026 | −$0.03 | — | — |
| Aug 2026 | −$0.07 | −$0.07 | −7.0% |
| Apr 2026 | −$0.13 | −$0.15 | −15.4% |
| Feb 2026 | $0.02 | $0.02 | 0.0% |
| Oct 2025 | −$0.06 | $0.00 | +93.3% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.29 | — | — | $238.4M | — | — | — |
| Sep 2028 | $0.24 | — | — | $224.3M | — | — | — |
| Jun 2028 | $0.21 | — | — | $214.2M | — | — | — |
| Mar 2028 | $0.07 | — | — | $178.2M | — | — | — |
| Dec 2027 | $0.10 | — | — | $169.9M | — | — | — |
| Sep 2027 | $0.06 | — | — | $151.9M | — | — | — |
| Jun 2027 | $0.03 | — | — | $138.4M | — | — | — |
| Mar 2027 | −$0.07 | — | — | $130.0M | — | — | — |
| Dec 2026 | $0.04 | — | — | $144.2M | — | — | — |
| Oct 29, 2026 | −$0.03 | — | — | $129.2M | — | — | — |
| Aug 6, 2026 | −$0.07 | −$0.07 | −7.0% | $121.0M | $120.9M | −0.1% | −17.9% |
| Apr 30, 2026 | −$0.13 | −$0.15 | −15.4% | $92.8M | $94.5M | +1.8% | +8.7% |
| Feb 19, 2026 | $0.02 | $0.02 | 0.0% | $118.0M | $125.2M | +6.1% | −15.0% |
| Oct 30, 2025 | −$0.06 | $0.00 | +93.3% | $119.1M | $110.3M | −7.3% | +21.0% |
| Aug 4, 2025 | |||||||
| May 1, 2025 | |||||||
| Feb 20, 2025 | |||||||
| Oct 31, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 2, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Oct 31, 2023 | |||||||
| Aug 2, 2023 | |||||||
| May 3, 2023 | |||||||
| Mar 2, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 13, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 8, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 6, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 9, 2019 | |||||||
| May 7, 2019 | |||||||
| Mar 6, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 8, 2018 | |||||||
| Mar 14, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 5, 2017 | |||||||
| Feb 17, 2017 | |||||||
| Nov 7, 2016 | |||||||
| Aug 8, 2016 | |||||||
| May 9, 2016 | |||||||
| Mar 4, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Aug 12, 2015 |